Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.

Bihl, F.; Russmann, S.; Gurtner, V.; Di Giammarino, L.; Pizzi-Bosman, L.; Michel, M.; Cerny, A.; Hadengue, A.; Majno, P.; Giostra, E.; Castelli, D.; Mentha, G.

doi:10.1186/1471-230X-10-71

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.

Détails

Demande d'une copie

ID Serval

serval:BIB_420F28766E70

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.

Périodique

BMC Gastroenterology

Auteur⸱e⸱s

Bihl F., Russmann S., Gurtner V., Di Giammarino L., Pizzi-Bosman L., Michel M., Cerny A., Hadengue A., Majno P., Giostra E., Castelli D., Mentha G.

ISSN

1471-230X[electronic], 1471-230X[linking]

Statut éditorial

Publié

Date de publication

2010

Volume

10

Pages

71

Langue

anglais

Notes

Publication types: Journal Article ; Research Support, Non-U.S. Gov't

Mots-clé

Adult, Antiviral Agents/therapeutic use, Cost-Benefit Analysis, Drug Therapy, Combination, Female, Follow-Up Studies, Hepatitis B/economics, Hepatitis B/immunology, Hepatitis B Antibodies/adverse effects, Hepatitis B Antibodies/economics, Humans, Immunoglobulins/economics, Immunoglobulins/therapeutic use, Liver Transplantation/immunology, Male, Middle Aged, Plasma, Recurrence/prevention & control, Treatment Outcome

OAI-PMH

oai:serval.unil.ch:BIB_420F28766E70

DOI

10.1186/1471-230X-10-71

Pubmed

20598161

Web of science

000282773600002

Open Access

Oui

Création de la notice

11/02/2011 14:55